483
QuVa Pharma, Inc.FDA 483 - QuVa Pharma, Inc. - June 16, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
QuVa Pharma, Inc. in Temple, TX, an outsourcing facility, received a Form 483 with four observations related to manufacturing and labeling deficiencies. Issues included unsanitary aseptic processing area floors, use of unvalidated software for BUDs, incomplete master production records, and missing required information on drug product labels. These observations indicate significant concerns regarding facility control, data integrity, and product quality.
Open in Dashboard
ID · f8ec5435-9552-4eeb-b316-1c4e191e2bb5